# Trade Mark Journal No.2025/036 5 September 2025

## UK00004253260 22 August 2025 (5)

International priority date claimed: 25 February 2025 (United States of America) (99056143)

Class 5
  Medicated and pharmaceutical preparations for the treatment and prevention of migraines; medicated and pharmaceutical preparations for the treatment and prevention of neurological disorders.

Axsome Therapeutics, Inc.

Representative: Keltie LLP